# High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia Prevention

> **NCT01355159** · PHASE3 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 2464 (actual)

## Conditions studied

- Pregnancy Complications
- Preeclampsia

## Interventions

- **DRUG:** Folic Acid 4 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01355159
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 2464 (ACTUAL)
- **Last updated:** 2020-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355159, "High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia Prevention". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01355159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*